We are live on ! Find out more
NC

Nucleo Capital Portfolio holdings

AUM $29.1M
1-Year Est. Return 59.16%
This Fund
S&P 500
This Quarter Est. Return
+11.62%
1 Year Est. Return
+59.16%
3 Year Est. Return
+115.74%
5 Year Est. Return
10 Year Est. Return
AUM
$288M
AUM Growth
+$45M
Cap. Flow
+$23.5M
Cap. Flow %
8.15%
Top 10 Hldgs %
100%
Holding
4
New
Increased
3
Reduced
1
Closed

Top Buys

Rank Stock Value
1
STNE icon
StoneCo
STNE
+$19.7M
2
MELI icon
Mercado Libre
MELI
+$9.45M
3
XP icon
XP
XP
+$106K

Top Sells

Rank Stock Value
1
CZZ
Cosan Limited
CZZ
+$5.8M

Sector Composition

Rank Sector Weight
1 Consumer Staples 35.1%
2 Technology 26.68%
3 Consumer Discretionary 25.28%
4 Financials 12.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CZZ
1
DELISTED
Cosan Limited
CZZ
$101M 35.1%
6,802,338
-328,700
-5% -$5.8M
STNE icon
2
StoneCo
STNE
$2.2B
$76.8M 26.68%
1,452,171
+412,510
+40% +$19.7M
MELI icon
3
Mercado Libre
MELI
$97.9B
$72.8M 25.28%
67,220
+8,710
+15% +$9.45M
XP icon
4
XP
XP
$8.97B
$37.2M 12.94%
893,330
+2,330
+0.3% +$106K

Similar funds

Nucleo Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Nucleo Capital held 4 positions worth $288M, up 19% from $243M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Nucleo Capital deployed $23.5M of net new capital in Q3 2020, adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Consumer Staples at 35% of assets, down from 44% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Cosan Limited, an estimated $5.8M trimmed.

  • Nucleo Capital added most to StoneCo in Q3 2020, an estimated $19.7M increase.
  • Nucleo Capital's biggest Q3 2020 reduction was Cosan Limited, cutting an estimated $5.8M.
  • Nucleo Capital's ten largest holdings make up 100% of its $288M portfolio in Q3 2020.
  • Nucleo Capital opened 0 new positions and closed 0 in Q3 2020.
  • Nucleo Capital's portfolio value rose 19% quarter-over-quarter to $288M.

Based on Nucleo Capital's 13F filing for Q3 2020, filed 10 Nov 2020.